Family Medicine · Omaha, NE
NPI
1790767713
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
7
Medicare group memberships
Hospitals
5
Hospital affiliations
4908 Cass St
Omaha, NE, 68132
Phone (402) 249-6136
Groups this clinician bills Medicare through
Medicare paid, 2024
$653K
20,082 services
Medicare patients, 2024
1,032
Average age 80
Drug cost, 2024
$4.0M
50,519 prescriptions
Company payments, 2025
$208
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rebecca M Wester was code 82962 (clinical chemistry), 10,241 times for 41 patients. In total Rebecca M Wester billed 20,082 services in 33 codes, and Medicare paid $653K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 82962 Clinical Chemistry | Office | 10,241 | 41 | $3.21 | $33K |
| 99309 SNF E&M | Office | 2,756 | 464 | $78.47 | $216K |
| 99308 SNF E&M | Office | 1,426 | 361 | $53.15 | $76K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,414 | 432 | $44.49 | $63K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 956 | 355 | $34.76 | $33K |
| 99487 Chronic, Principal, and Transitional Care Management | Office | 478 | 160 | $98.54 | $47K |
| 99497 Care Management/Coordination | Office | 449 | 304 | $52.99 | $24K |
| 99309 SNF E&M | Facility | 392 | 190 | $78.53 | $31K |
| 99310 SNF E&M | Office | 288 | 201 | $106.96 | $31K |
| 36415 Venipuncture Blood Collection | Office | 287 | 123 | $8.65 | $2,483 |
| 99489 Chronic, Principal, and Transitional Care Management | Office | 225 | 81 | $53.17 | $12K |
| 99306 SNF E&M | Facility | 146 | 142 | $131.33 | $19K |
| 99349 Home E&M - New and Established | Office | 133 | 76 | $90.92 | $12K |
| 99211 Office E&M - Established | Office | 126 | 43 | $14.20 | $1,789 |
| 99310 SNF E&M | Facility | 114 | 96 | $110.98 | $13K |
By year: 2022 $361K for 5,612 services; 2023 $425K for 13,119 services; 2024 $653K for 20,082 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 10,241 | 41 | $3.21 | $33K |
| 36415 Venipuncture Blood Collection | 287 | 123 | $8.65 | $2,483 |
Medicare prescription drug claims, 2024
In 2024, the drug Rebecca M Wester prescribed most often to Medicare patients was Eliquis (Apixaban), with 1,823 prescriptions and refills. In total Rebecca M Wester wrote 50,519 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 1,823 | 1,827 | 179 | $573K |
| Levothyroxine Sodium Generic | 1,740 | 1,761 | 229 | $22K |
| Atorvastatin Calcium Generic | 1,698 | 1,705 | 289 | $30K |
| Sertraline Hcl Generic | 1,522 | 1,531 | 220 | $25K |
| Gabapentin Generic | 1,430 | 1,438 | 225 | $43K |
| Trazodone Hcl Generic | 1,399 | 1,406 | 233 | $22K |
| Furosemide Generic | 1,331 | 1,342 | 218 | $9,651 |
| Amlodipine Besylate Generic | 1,306 | 1,331 | 219 | $13K |
| Pantoprazole Sodium Generic | 1,116 | 1,118 | 189 | $24K |
| Tamsulosin Hcl Generic | 1,041 | 1,041 | 153 | $24K |
| Duloxetine Hcl Generic | 1,020 | 1,020 | 142 | $35K |
| Potassium Chloride Generic | 994 | 997 | 168 | $32K |
| Losartan Potassium Generic | 936 | 944 | 151 | $14K |
| Metoprolol Tartrate Generic | 870 | 872 | 134 | $10K |
| Metoprolol Succinate Generic | 846 | 866 | 145 | $15K |
Brand drugs: 9,156 claims; generic drugs: 41,028 claims; opioid claims: 1,389.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rebecca M Wester $208 ($208 in general payments such as food, travel and fees) from 3 companies. The largest payer was Otsuka America Pharmaceutical, Inc. with $121.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.